Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
Categories
Biotech Pharmaceutical
About
Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynConr vaccines are designed to generate universal responses against multiple unmatched strains of pathogens. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile. 4/8/15 - A federal agency has selected Inovio Pharmaceuticals Inc. to lead an effort to develop multiple treatment and prevention approaches against Ebola. The effort is being funded through a $45 million grant from the Defense Advanced Research Projects Agency, an agency of the Department of Defense
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.